Zotarolimus (INN codenamed ABT-578) is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier. Coronary stents reduce early […]
List of articles in "Drug" category - Page 250
Aflibercept
Aflibercept (INN USAN) is a biopharmaceutical drug invented by Regeneron Pharmaceuticals approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea […]
Propylnorapomorphine
N-n-Propylnorapomorphine (NPA) is an aporphine derivative dopamine agonist closely related to apomorphine. In rodents it has been shown to produce hyperactivity stereotypy hypothermia antinociception and penile erection among other effects. […]
Laropiprant
Laropiprant (INN) is used in combination with niacin to reduce blood cholesterol (LDL and VLDL). Merck & Co. planned to market this combination under the trade names Cordaptive in the […]
A-412997
A-412997 is a drug which acts as a dopamine agonist that is used in scientific research. It is the first drug developed that is a highly selective agonist for the […]
Norbinaltorphimine
Norbinaltorphimine (nor-BNI or nBNI) is an opioid antagonist used in scientific research. It is one of the few opioid antagonists available that is highly selective for the κ-opioid receptor and […]
Eseroline
Eseroline is a drug which acts as an opioid agonist. It is a metabolite of the acetylcholinesterase inhibitor physostigmine but unlike physostigmine the acetylcholinesterase inhibition produced by eseroline is weak […]
O-1238
O-1238 is a drug which is a cannabinoid derivative that is used in scientific research. It is a partial agonist at the cannabinoid receptor CB1 producing a maximal stimulation of […]
O-823
O-823 is a drug which is a cannabinoid derivative that is used in scientific research. It is described as a mixed agonist/antagonist at the cannabinoid receptor CB1 meaning that it […]
O-806
O-806 is a drug which is a cannabinoid derivative that is used in scientific research. It is described as a mixed agonist/antagonist at the cannabinoid receptor CB1 meaning that it […]